Clinical Trial Update: A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating erythropoietic response in hepatitis C patients treated with ribavirin plus interferon or ribavirin plus pegylated interferon; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hepatitis C

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Pegylated interferon alfa (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Ortho Biotech Products, L.P. | Conditions: Hepatitis C, Anemia | Phase 2 | Status: COMPLETED